capecitabine has been researched along with Pelvic Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agolli, L; Borro, M; Bracci, S; De Sanctis, V; Di Nardo, F; Enrici, RM; Falco, T; Gentile, G; Maglio, M; Minniti, G; Nicosia, L; Osti, MF; Simmaco, M; Valeriani, M | 1 |
1 other study(ies) available for capecitabine and Pelvic Pain
| Article | Year |
|---|---|
Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Cystitis; Diarrhea; DNA-Binding Proteins; Female; Fluorouracil; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pelvic Pain; Polymorphism, Single Nucleotide; Proctitis; Rad51 Recombinase; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Rectal Neoplasms; X-ray Repair Cross Complementing Protein 1 | 2017 |